Switch theme
Sign up to access all valuation multiples
Scandinavian Real Heart AB is engaged in developing an artificial heart.
1999
11
Last FY Revenue n/a
Last FY EBITDA -$3.5M
$1.3M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Scandinavian Real Heart achieved revenue of n/a and an EBITDA of -$3.5M.
Scandinavian Real Heart expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Scandinavian Real Heart valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | n/a | XXX | XXX | XXX |
| Gross Profit | XXX | $2.9M | XXX | XXX | XXX |
| Gross Margin | XXX | n/a | XXX | XXX | XXX |
| EBITDA | XXX | -$3.5M | XXX | XXX | XXX |
| EBITDA Margin | XXX | n/a | XXX | XXX | XXX |
| EBIT | XXX | -$1.6M | XXX | XXX | XXX |
| EBIT Margin | XXX | n/a | XXX | XXX | XXX |
| Net Profit | XXX | -$3.5M | XXX | XXX | XXX |
| Net Margin | XXX | n/a | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Scandinavian Real Heart's stock price is SEK 14 (or $1).
Scandinavian Real Heart has current market cap of SEK 30.1M (or $3.1M), and EV of SEK 12.8M (or $1.3M).
See Scandinavian Real Heart trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.3M | $3.1M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Scandinavian Real Heart has market cap of $3.1M and EV of $1.3M.
Scandinavian Real Heart's trades at n/a EV/Revenue multiple, and -0.4x EV/EBITDA.
Equity research analysts estimate Scandinavian Real Heart's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Scandinavian Real Heart's P/E ratio is not available.
See valuation multiples for Scandinavian Real Heart and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3.1M | XXX | $3.1M | XXX | XXX | XXX |
| EV (current) | $1.3M | XXX | $1.3M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | n/a | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -0.4x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -0.8x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -0.9x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -0.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialScandinavian Real Heart's revenue per employee in the last FY averaged n/a, while opex per employee averaged $0.4M for the same period.
Scandinavian Real Heart's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Scandinavian Real Heart's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Scandinavian Real Heart and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Scandinavian Real Heart acquired XXX companies to date.
Last acquisition by Scandinavian Real Heart was XXXXXXXX, XXXXX XXXXX XXXXXX . Scandinavian Real Heart acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Scandinavian Real Heart founded? | Scandinavian Real Heart was founded in 1999. |
| Where is Scandinavian Real Heart headquartered? | Scandinavian Real Heart is headquartered in Sweden. |
| How many employees does Scandinavian Real Heart have? | As of today, Scandinavian Real Heart has 11 employees. |
| Is Scandinavian Real Heart publicy listed? | Yes, Scandinavian Real Heart is a public company listed on STO. |
| What is the stock symbol of Scandinavian Real Heart? | Scandinavian Real Heart trades under HEART ticker. |
| When did Scandinavian Real Heart go public? | Scandinavian Real Heart went public in 2014. |
| Who are competitors of Scandinavian Real Heart? | Similar companies to Scandinavian Real Heart include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Scandinavian Real Heart? | Scandinavian Real Heart's current market cap is $3.1M |
| Is Scandinavian Real Heart profitable? | Yes, Scandinavian Real Heart is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
